[
    {
        "src": "COCC(O)CNC(=O)c1n[nH]c2cc(NC(=O)NC(C)c3ccccc3)ncc12",
        "tgt": "CC(NC(=O)Nc1cc2[nH]nc(NS(=O)(=O)CC3CC3)c2cn1)c1ccccc1",
        "src_logd": 2.6213739080366265,
        "tgt_logd": 2.235222825734396,
        "src_solubility": 1.6224580785374436,
        "tgt_solubility": 1.5327059266039575,
        "src_clint": 0.9481797699877405,
        "tgt_clint": 0.4027306950031579,
        "src_qed": 0.3803144667767853,
        "tgt_qed": 0.47230992732218313,
        "src_drd2": 0.0006190715577324411,
        "tgt_drd2": 0.0011287259829880249,
        "src_jnk3": 0.05,
        "tgt_jnk3": 0.1,
        "src_gsk": 0.13,
        "tgt_gsk": 0.46,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The source molecule contains a bicyclic aromatic core (imidazo[1,2-b]pyridazine) with a carbamate group (COCC(O)), a urea linker (NC(=O)NC), and a methyl-substituted benzyl group. The imidazo[1,2-b]pyridazine scaffold is critical for kinase binding, while the carbamate and urea groups may contribute to solubility and hydrogen bonding.\",\n    \"Property Analysis\": \"GSK3-beta inhibitors require strong ATP-competitive binding. Key features include (1) a planar heteroaromatic core for hinge-region interactions, (2) substituents for hydrophobic pocket occupancy, and (3) polar groups for solubility and selectivity. The carbamate group may introduce metabolic instability, and the urea linker could limit conformational rigidity.\",\n    \"Limitation in Source Molecule for Property\": \"1) Carbamate (COCC(O)) is prone to hydrolysis, reducing metabolic stability. 2) Urea linker (NC(=O)NC) lacks optimal directional hydrogen bonding. 3) Limited hydrophobic bulk for affinity enhancement. 4) No electron-withdrawing groups to modulate \u03c0-stacking in the ATP-binding pocket.\",\n    \"Optimization for Source Molecule\": \"1) Replace carbamate with sulfonamide (NSO2) for metabolic stability and stronger hydrogen bonding. 2) Substitute urea with sulfonylurea (NHSO2N) to enhance rigidity and binding orientation. 3) Introduce cyclopropyl-sulfonyl group (CC3CC3)S(=O)=O) to occupy the hydrophobic pocket. 4) Retain imidazo[1,2-b]pyridazine core while optimizing substituent positions.\",\n    \"Final Target Molecule\": \"CC(NC(=O)Nc1cc2[nH]nc(NS(=O)(=O)CC3CC3)c2cn1)c1ccccc1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "CNc1ncnc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)n1",
        "tgt": "CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)n1",
        "src_logd": 4.370207306499697,
        "tgt_logd": 4.799984636745959,
        "src_solubility": -0.1304337709139966,
        "tgt_solubility": -0.497402471954477,
        "src_clint": 1.9426479548193785,
        "tgt_clint": 1.9227768026162697,
        "src_qed": 0.3837241159410864,
        "tgt_qed": 0.355207923865328,
        "src_drd2": 0.00560448969643238,
        "tgt_drd2": 0.007558540286584105,
        "src_jnk3": 0.02,
        "tgt_jnk3": 0.14,
        "src_gsk": 0.09,
        "tgt_gsk": 0.41,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The source molecule contains a pyrimidine core (ncnc) substituted with a methylamine group (CN) and a biphenyl ether moiety. The biphenyl ether has a trifluoromethyl (CF3) group and a carbonyl-linked aniline (C(=O)Nc3cccc(C(F)(F)F)c3). The structure features multiple hydrogen bond acceptors (nitrogens, carbonyl) and hydrophobic regions (CF3, aromatic rings).\",\n    \"Property Analysis\": \"GSK3-beta inhibition typically requires interactions with the ATP-binding pocket, involving hydrogen bonding to hinge-region residues (e.g., Asp133) and hydrophobic complementarity. The pyrimidine core may engage in hinge interactions, while the CF3 group enhances lipophilic binding. However, electronic/steric mismatches in the core could limit potency.\",\n    \"Limitation in Source Molecule for Property\": \"The pyrimidine's electron-deficient nature (two adjacent nitrogens) may reduce optimal \u03c0-stacking in the hydrophobic pocket. The ncnc arrangement creates a planar geometry that might misalign with hinge-region hydrogen bonding preferences, limiting binding efficiency.\",\n    \"Optimization for Source Molecule\": \"Replace the pyrimidine core (ncnc) with a pyridine ring (nccc) to reduce electron deficiency while retaining hydrogen bonding capability. This modification improves hydrophobic stacking and aligns the methylamine group for better hinge-region interactions. The CF3 and carbonyl groups are retained to maintain hydrophobic and hydrogen bonding contributions.\",\n    \"Final Target Molecule\": \"CNc1nccc(-c2cccnc2Oc2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2C)n1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "CCOC(=O)C1(C(=O)NC(Cc2ccc(-c3ccccc3OC)cc2)C(=O)O)CCCO1",
        "tgt": "COc1ccccc1-c1ccc(CC(NC(=O)Cc2ccncc2)C(=O)O)cc1",
        "src_logd": -0.0374036643991471,
        "tgt_logd": -0.5144669604936483,
        "src_solubility": 2.6605110651677184,
        "tgt_solubility": 2.8905331938557284,
        "src_clint": 1.8298554149871,
        "tgt_clint": 1.2627377824505943,
        "src_qed": 0.45445219384192387,
        "tgt_qed": 0.6169873132967414,
        "src_drd2": 0.001791538877012609,
        "tgt_drd2": 0.0050926856819183625,
        "src_jnk3": 0.0,
        "tgt_jnk3": 0.01,
        "src_gsk": 0.04,
        "tgt_gsk": 0.34,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The source molecule contains an ethyl ester, a cyclic carbonate/lactone ring, and a substituted biphenyl system with methoxy and amide groups. The ester and carbonate functionalities introduce metabolic liabilities, while the bulky cyclic ring may hinder binding interactions.\",\n    \"Property Analysis\": \"GSK3-beta inhibitors typically require planar aromatic systems for ATP-pocket binding, hydrogen bond donors/acceptors, and moderate lipophilicity. The source molecule's ester groups reduce metabolic stability, and the cyclic carbonate introduces conformational flexibility, potentially reducing target affinity.\",\n    \"Limitation in Source Molecule for Property\": \"1) Ester groups (CCOC(=O)) are prone to hydrolysis. 2) The cyclic carbonate (CCCO1) reduces rigidity and may impede optimal binding geometry. 3) The methoxy group (-OC) on the distal phenyl ring limits hydrogen-bonding potential. 4) High rotatable bond count reduces ligand efficiency.\",\n    \"Optimization for Source Molecule\": \"1) Replace esters with stable amides. 2) Substitute cyclic carbonate with a rigid biphenyl system. 3) Introduce pyridine as a hydrogen bond acceptor. 4) Reposition methoxy to enhance \u03c0-stacking. 5) Incorporate secondary amides for improved solubility and H-bond interactions.\",\n    \"Final Target Molecule\": \"COc1ccccc1-c1ccc(CC(NC(=O)Cc2ccncc2)C(=O)O)cc1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "CC(C)CC(NC(c1ccc(-c2ccc(C#N)cc2)cc1)C(F)(F)F)C(=O)NCC#N",
        "tgt": "CC(C)CC(NC(c1ccc(-c2ccncc2)cc1)C(F)(F)F)C(=O)NCC#N",
        "src_logd": 3.9273841059704777,
        "tgt_logd": 3.3928570680262338,
        "src_solubility": 0.9665673178157568,
        "tgt_solubility": 1.8270454080913805,
        "src_clint": 1.3166408533650955,
        "tgt_clint": 1.8484241063828808,
        "src_qed": 0.6073095753526225,
        "tgt_qed": 0.6523111491633898,
        "src_drd2": 0.016536501598408384,
        "tgt_drd2": 0.01841428636607035,
        "src_jnk3": 0.01,
        "tgt_jnk3": 0.05,
        "src_gsk": 0.07,
        "tgt_gsk": 0.41,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The molecule contains a central aliphatic chain with a tert-butyl group, an amide-linked trifluoromethylphenyl group, and a cyanomethyl substituent. The aromatic system includes a biphenyl moiety with a para-cyano group on one phenyl ring.\",\n    \"Property Analysis\": \"GSK3-beta inhibition requires strong binding to the ATP-binding pocket, involving hydrogen bonding with key residues (e.g., Val135, Asp133) and hydrophobic interactions. The cyano group may act as a weak hydrogen bond acceptor, while the trifluoromethyl group contributes hydrophobicity.\",\n    \"Limitation in Source Molecule for Property\": \"The biphenyl system with a para-cyano substituent may cause suboptimal binding due to (1) excessive rigidity reducing conformational adaptability, (2) limited hydrogen bonding capacity of the cyano group, and (3) potential steric clashes from the linear nitrile group.\",\n    \"Optimization for Source Molecule\": \"Replace the para-cyano-substituted benzene ring with pyridine to: 1) Introduce a stronger hydrogen bond acceptor (pyridinic N), 2) Maintain planarity while reducing steric bulk, 3) Improve solubility through heteroaromaticity, 4) Preserve \u03c0-\u03c0 stacking capability.\",\n    \"Final Target Molecule\": \"CC(C)CC(NC(c1ccc(-c2ccncc2)cc1)C(F)(F)F)C(=O)NCC#N\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "Cc1c(F)ccc(C(=O)Nc2cc(C(=O)O)ccc2N2CCN(C)CC2)c1Cl",
        "tgt": "Cc1c(F)ccc(C(=O)Nc2cc(-c3ccncc3)ccc2N2CCN(C)CC2)c1Cl",
        "src_logd": -0.5421575869439947,
        "tgt_logd": 3.801590817484637,
        "src_solubility": 2.065632119834322,
        "tgt_solubility": 1.0249263097328898,
        "src_clint": 0.8651553862476363,
        "tgt_clint": 1.8899309204719832,
        "src_qed": 0.8141967943403285,
        "tgt_qed": 0.6319778082552967,
        "src_drd2": 0.03428089154504634,
        "tgt_drd2": 0.3846702052953137,
        "src_jnk3": 0.0,
        "tgt_jnk3": 0.06,
        "src_gsk": 0.0,
        "tgt_gsk": 0.34,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The molecule contains a dichlorophenyl ring connected via an amide linker to a substituted phenyl ring with a carboxylic acid group and a piperazine moiety. The fluorine and chlorine substituents contribute to electronic and steric effects.\",\n    \"Property Analysis\": \"The carboxylic acid group (C(=O)O) may limit cell permeability due to ionization at physiological pH, reducing bioavailability. The planar aromatic systems may restrict optimal binding to GSK3-beta's ATP-binding pocket.\",\n    \"Limitation in Source Molecule for Property\": \"1) Ionizable carboxylic acid reduces membrane permeability. 2) Limited 3D diversity in the central aromatic region may hinder optimal interactions with the hydrophobic region of GSK3-beta.\",\n    \"Optimization for Source Molecule\": \"Replace the carboxylic acid (-C(=O)O) with a neutral bioisostere (e.g., pyridyl group) to improve lipophilicity and permeability. Maintain the amide linker for hydrogen bonding with kinase hinge region. Retain halogen substituents (Cl, F) for hydrophobic interactions and piperazine for solubility.\",\n    \"Final Target Molecule\": \"Cc1c(F)ccc(C(=O)Nc2cc(-c3ccncc3)ccc2N2CCN(C)CC2)c1Cl\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "CN1CCN(CCCNc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)CC1",
        "tgt": "COc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1",
        "src_logd": 2.1076548905379275,
        "tgt_logd": 4.14711893029954,
        "src_solubility": 3.253232139080123,
        "tgt_solubility": -0.1358903317440678,
        "src_clint": 1.4219850643720502,
        "tgt_clint": 1.8819898249492104,
        "src_qed": 0.568439967544195,
        "tgt_qed": 0.4935322643431872,
        "src_drd2": 0.23102399253206637,
        "tgt_drd2": 0.003049181732089922,
        "src_jnk3": 0.25,
        "tgt_jnk3": 0.34,
        "src_gsk": 0.25,
        "tgt_gsk": 0.61,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The source molecule contains a piperazine core linked via a propyl chain to a substituted quinazolinone scaffold. Key features include two chlorinated aromatic rings, a tertiary amine in the piperazine, and a carbonyl group. The structure exhibits moderate rigidity but has a flexible propyl linker.\",\n    \"Property Analysis\": \"GSK3-beta inhibitors require strong hydrogen bonding with the kinase hinge region (e.g., via carbonyl groups), hydrophobic filling of the ATP-binding pocket (enhanced by chlorinated aromatics), and proper spatial orientation. The piperazine may contribute to solubility but adds unnecessary flexibility.\",\n    \"Limitation in Source Molecule for Property\": \"1) The propyl linker introduces conformational entropy penalties. 2) Piperazine's basic nitrogen may cause off-target interactions. 3) Limited planar aromatic surface for optimal ATP-pocket stacking. 4) Methyl groups on quinazolinone nitrogen restrict hydrogen bonding potential.\",\n    \"Optimization for Source Molecule\": \"1) Replace flexible piperazine-propyl system with rigid methoxyphenyl group to enhance aromatic stacking. 2) Maintain chlorinated hydrophobic anchors. 3) Retain quinazolinone carbonyl as hinge-binder. 4) Introduce methoxy group for improved solubility and potential hydrogen bonding. 5) Remove methyl from quinazolinone nitrogen to enable hydrogen donor interactions.\",\n    \"Final Target Molecule\": \"COc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "COc1cccc(Cl)c1-c1ccc(COC2COc3nc([N+](=O)[O-])cn3C2)cc1",
        "tgt": "O=[N+]([O-])c1cn2c(n1)OCC(OCc1ccc(-c3ccncc3)cc1)C2",
        "src_logd": 2.9523086564257413,
        "tgt_logd": 1.7709360925746451,
        "src_solubility": 0.6370402461570407,
        "tgt_solubility": 2.023704935360593,
        "src_clint": 1.5652779090065116,
        "tgt_clint": 1.3032312779432245,
        "src_qed": 0.4445636561277318,
        "tgt_qed": 0.5177714052397565,
        "src_drd2": 0.0006244346147868863,
        "tgt_drd2": 0.0028330827945049347,
        "src_jnk3": 0.03,
        "tgt_jnk3": 0.09,
        "src_gsk": 0.06,
        "tgt_gsk": 0.42,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The molecule contains two aromatic rings connected by a single bond. One ring has a methoxy (COC) and chloro substituent, while the other is linked to a nitrile-containing heterocycle with a nitro group ([N+](=O)[O-]). The structure includes ether and methyl ether linkages, contributing to rigidity and moderate polarity.\",\n    \"Property Analysis\": \"The nitro group and chloro substituent enhance electron-withdrawing effects, potentially aiding binding to GSK3-beta. However, the nitrile-heterocycle may limit hydrogen-bonding interactions. The methoxy groups improve solubility but reduce hydrophobic interactions in the kinase pocket.\",\n    \"Limitation in Source Molecule for Property\": \"(1) Nitrile group lacks strong hydrogen-bonding capacity. (2) Chloro substituent may contribute to off-target toxicity. (3) Methoxy groups reduce hydrophobic complementarity with the ATP-binding site. (4) Suboptimal spatial arrangement of the nitro group for kinase inhibition.\",\n    \"Optimization for Source Molecule\": \"(1) Replace nitrile-heterocycle with a pyridine ring to enhance hydrogen bonding. (2) Substitute chloro with a bioisostere (e.g., pyridine ring) to maintain hydrophobicity while reducing toxicity. (3) Reposition nitro group to optimize kinase pocket interactions. (4) Introduce a morpholine-like oxygen-rich ring to improve solubility and binding affinity.\",\n    \"Final Target Molecule\": \"O=[N+]([O-])c1cn2c(n1)OCC(OCc1ccc(-c3ccncc3)cc1)C2\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "CC(NC(=O)Nc1cc2[nH]nc(C(=O)N3CC(=O)N(C)C3)c2cn1)c1ccccc1",
        "tgt": "CC(NC(=O)Nc1cc2[nH]nc(Nc3ccccc3)c2cn1)c1ccccc1",
        "src_logd": 2.4128400760605,
        "tgt_logd": 4.2142079423486445,
        "src_solubility": 0.7365775863201333,
        "tgt_solubility": 0.510468237642959,
        "src_clint": 1.1551471292477364,
        "tgt_clint": 0.9871962312107364,
        "src_qed": 0.607534945506058,
        "tgt_qed": 0.41220270057621544,
        "src_drd2": 0.00017621369454759821,
        "tgt_drd2": 0.004394103976333583,
        "src_jnk3": 0.05,
        "tgt_jnk3": 0.25,
        "src_gsk": 0.19,
        "tgt_gsk": 0.5,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The source molecule contains a central benzamide core with a substituted quinazolinone ring. Key features include a urea linker (NC(=O)N), a morpholine-derived substituent (C(=O)N3CC(=O)N(C)C3), and a benzyl group attached to the central amine. The quinazolinone ring has hydrogen bond donor/acceptor potential via the [nH] and carbonyl groups.\",\n    \"Property Analysis\": \"GSK3-beta inhibitors typically require hydrogen bonding (with residues like Asp133, Val135) and hydrophobic interactions (with hinge region and allosteric pockets). The morpholine substituent may introduce excessive polarity or steric bulk, reducing binding efficiency. The urea linker provides rigidity and hydrogen bonding but may limit conformational flexibility.\",\n    \"Limitation in Source Molecule for Property\": \"The morpholine-derived substituent (C(=O)N3CC(=O)N(C)C3) introduces redundant polarity from two carbonyl groups and steric hindrance, potentially disrupting hydrophobic interactions. The rigid urea linker may restrict optimal positioning of the benzyl group in the hydrophobic pocket.\",\n    \"Optimization for Source Molecule\": \"Replace the morpholine-derived substituent with a phenyl group to enhance hydrophobic interactions and reduce polarity. Retain the urea linker for hydrogen bonding while simplifying the substituent to improve binding affinity and pharmacokinetics.\",\n    \"Final Target Molecule\": \"CC(NC(=O)Nc1cc2[nH]nc(Nc3ccccc3)c2cn1)c1ccccc1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "COc1ccc(NC(=O)Cc2c(C)n(C(=O)c3ccc(Cl)cc3)c3ccc(OC)cc23)cc1",
        "tgt": "COc1ccc2c(c1)c(CC(=O)Nc1ncc([N+](=O)[O-])s1)c(C)n2C(=O)c1ccc(Cl)cc1",
        "src_logd": 4.490890807914295,
        "tgt_logd": 4.1914168283626845,
        "src_solubility": -0.2761471205965416,
        "tgt_solubility": 0.1940773781324469,
        "src_clint": 2.047471472406757,
        "tgt_clint": 1.938766926668956,
        "src_qed": 0.4110610977680987,
        "tgt_qed": 0.30875572262873024,
        "src_drd2": 0.0010844384451863883,
        "tgt_drd2": 0.00034696285832771563,
        "src_jnk3": 0.01,
        "tgt_jnk3": 0.1,
        "src_gsk": 0.0,
        "tgt_gsk": 0.36,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The source molecule contains a bicyclic core with a methoxy-substituted benzene ring, an amide-linked aniline group, and a chlorine-substituted aromatic ring. The bicyclic system includes a cyclopropane fused to a benzene ring, with methyl and methoxy substituents.\",\n    \"Property Analysis\": \"GSK3-beta inhibitors require hydrogen-bond donors/acceptors, hydrophobic interactions, and proper steric fit. The amide groups and aromatic systems in the source molecule provide partial binding potential, but key interactions with the kinase's ATP-binding pocket are suboptimal.\",\n    \"Limitation in Source Molecule for Property\": \"1) Lack of strong electron-withdrawing groups to enhance hinge-region interactions. 2) Bulky methoxy groups may hinder optimal binding. 3) Limited hydrogen-bonding capacity in the bicyclic region. 4) Suboptimal solubility due to high lipophilicity.\",\n    \"Optimization for Source Molecule\": \"1) Introduce a nitro group ([N+](=O)[O-]) as a strong electron-withdrawing substituent to improve hinge-region binding. 2) Replace a methoxy group with a thiazole ring to enhance planarity and hydrogen-bond acceptance. 3) Position the nitro group on the thiazole to maximize interaction with catalytic lysine. 4) Maintain chlorine for hydrophobic complementarity while improving solubility via heterocycle incorporation.\",\n    \"Final Target Molecule\": \"COc1ccc2c(c1)c(CC(=O)Nc1ncc([N+](=O)[O-])s1)c(C)n2C(=O)c1ccc(Cl)cc1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "COc1ccccc1N(C)c1cc[nH]c(=O)c1C(=O)Nc1ccc(N2CCN(C)CC2)cc1",
        "tgt": "CN1CCN(c2ccc(NC(=O)c3c(Nc4ccnc(N)n4)cc[nH]c3=O)cc2)CC1",
        "src_logd": 1.7376358488944557,
        "tgt_logd": 0.5156271109812043,
        "src_solubility": 2.4767982962404824,
        "tgt_solubility": 2.555267754328297,
        "src_clint": 1.5710234311093274,
        "tgt_clint": 1.2902793170863034,
        "src_qed": 0.6043274735062786,
        "tgt_qed": 0.48813751263353883,
        "src_drd2": 0.03834853168427797,
        "tgt_drd2": 0.02359393508980116,
        "src_jnk3": 0.01,
        "tgt_jnk3": 0.19,
        "src_gsk": 0.03,
        "tgt_gsk": 0.35,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The molecule contains a methoxy-substituted benzene ring, an N-methyl aniline group, a pyridine-derived amide core, and a terminal piperazine-linked aromatic ring. Key features include hydrogen-bond acceptors (amide, pyridine, ether) and a tertiary amine (piperazine).\",\n    \"Property Analysis\": \"GSK3-beta inhibitors require strong ATP-binding pocket interactions. The source molecule likely has moderate affinity due to hydrogen-bonding amides and aromatic stacking, but suboptimal interactions with key residues (e.g., Asp133, Val135).\",\n    \"Limitation in Source Molecule for Property\": \"1) Methoxy group lacks strong H-bond donor capacity. 2) N-methyl on aniline blocks potential H-bond donation. 3) Flexible piperazine may reduce target engagement. 4) Pyridine's electron-deficient nature limits optimal \u03c0-\u03c0 interactions.\",\n    \"Optimization for Source Molecule\": \"1) Replace methoxy with amino group (-NH2) to enhance H-bond donation. 2) Remove N-methyl from aniline to expose H-bond donor. 3) Replace piperazine with rigid piperidine to improve binding pose stability. 4) Introduce pyrimidine ring (vs pyridine) for stronger \u03c0-stacking and additional H-bond acceptance.\",\n    \"Final Target Molecule\": \"CN1CCN(c2ccc(NC(=O)c3c(Nc4ccnc(N)n4)cc[nH]c3=O)cc2)CC1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "O=C(NC(Cc1ccc(O)cc1)C(=O)NCC1CC(Br)=NO1)OCc1ccccc1",
        "tgt": "O=C(NC(Cc1c[nH]c2ncccc12)C(=O)NCC1CC(Br)=NO1)OCc1ccccc1",
        "src_logd": 2.5997670509358928,
        "tgt_logd": 2.9964148251322937,
        "src_solubility": 1.9813897732739187,
        "tgt_solubility": 1.4019450415005703,
        "src_clint": 1.8566345626883352,
        "tgt_clint": 2.473737725686678,
        "src_qed": 0.5431862123775203,
        "tgt_qed": 0.43977441349252905,
        "src_drd2": 0.0014147184938281864,
        "tgt_drd2": 0.004602114034991171,
        "src_jnk3": 0.01,
        "tgt_jnk3": 0.06,
        "src_gsk": 0.01,
        "tgt_gsk": 0.35,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The molecule contains a central amide core with a phenolic ring (Cc1ccc(O)cc1), a brominated morpholine-oxime moiety (NCC1CC(Br)=NO1), and a benzyl ester group (OCc1ccccc1). Key features include hydrogen bond donors (amide NH, phenolic OH), acceptors (amide carbonyl, oxime, ester carbonyl), and hydrophobic regions (aromatic rings).\",\n    \"Property Analysis\": \"GSK3-beta inhibitors often require strong hydrogen bonding with the kinase's ATP-binding pocket, hydrophobic complementarity, and proper stereoelectronic properties. The phenolic OH and amide groups likely contribute to binding, but the planar aromatic system may lack optimal interactions.\",\n    \"Limitation in Source Molecule for Property\": \"The phenolic ring lacks heteroaromaticity, reducing \u03c0-\u03c0 stacking and hydrogen bonding potential. The para-substituted OH may have limited spatial alignment with key residues. The morpholine-oxime's rigidity could restrict conformational adaptability.\",\n    \"Optimization for Source Molecule\": \"Replace the phenolic ring with an indole scaffold to introduce heteroaromaticity (enhanced \u03c0-\u03c0 stacking) and an additional hydrogen bond donor (N-H). This modification improves complementarity to the hydrophobic pocket and strengthens interactions with catalytic residues (e.g., Lys85, Asp133).\",\n    \"Final Target Molecule\": \"O=C(NC(Cc1c[nH]c2ncccc12)C(=O)NCC1CC(Br)=NO1)OCc1ccccc1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "Cc1cc(C(N)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-c2cnn(C)c2)cc1",
        "tgt": "Cc1cc(C(N)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-c2ccncc2)cc1",
        "src_logd": 0.078936539403259,
        "tgt_logd": 0.3511532807376523,
        "src_solubility": 2.6251774980403733,
        "tgt_solubility": 2.4656688899532644,
        "src_clint": 0.8873828556302438,
        "tgt_clint": 0.9575493739555496,
        "src_qed": 0.46478838409280343,
        "tgt_qed": 0.45093494046848975,
        "src_drd2": 0.004396509583458545,
        "tgt_drd2": 0.009305043981298914,
        "src_jnk3": 0.07,
        "tgt_jnk3": 0.07,
        "src_gsk": 0.1,
        "tgt_gsk": 0.4,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The source molecule contains three aromatic systems: a methyl-substituted benzene with a carboxamide group, a pyridine ring with a propionic acid substituent, and a terminal benzene linked to a 1,2,3-triazole methyl derivative. The triazole group introduces steric bulk and potential metabolic instability.\",\n    \"Property Analysis\": \"GSK3-beta inhibitors often require planar aromatic systems for binding pocket compatibility, hydrogen bond donors/acceptors (e.g., carboxamide, carboxylic acid), and optimal solubility. The triazole's methyl group and strained geometry may disrupt \u03c0-\u03c0 stacking or induce unfavorable steric clashes.\",\n    \"Limitation in Source Molecule for Property\": \"The 1,2,3-triazole methyl group (c2cnn(C)c2) introduces steric hindrance, reduces planarity, and limits \u03c0-\u03c0 interactions. The methyl group on the triazole nitrogen may also decrease solubility and metabolic stability.\",\n    \"Optimization for Source Molecule\": \"Replace the 1,2,3-triazole methyl group with a pyridine ring (c2ccncc2). Pyridine enhances planarity, improves \u03c0-\u03c0 stacking, removes steric bulk, and increases solubility via its lone pair of electrons. This modification retains aromaticity while aligning with GSK3-beta's hydrophobic pocket requirements.\",\n    \"Final Target Molecule\": \"Cc1cc(C(N)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-c2ccncc2)cc1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "CN1C(=O)C(Cc2ccc(-c3ccccc3[N+](=O)[O-])cc2)NC(=O)c2cc(Cl)ccc21",
        "tgt": "CN1C(=O)C(Cc2ccc(-c3ccncc3)cc2)NC(=O)c2cc(Cl)ccc21",
        "src_logd": 3.315843921936949,
        "tgt_logd": 2.9216064239880413,
        "src_solubility": 0.3722017527107801,
        "tgt_solubility": 0.4672299982488628,
        "src_clint": 1.884168297969216,
        "tgt_clint": 1.7275355846466616,
        "src_qed": 0.48985520694039336,
        "tgt_qed": 0.7397275001981332,
        "src_drd2": 0.0032583908699405062,
        "tgt_drd2": 0.0068560864505949805,
        "src_jnk3": 0.14,
        "tgt_jnk3": 0.05,
        "src_gsk": 0.15,
        "tgt_gsk": 0.48,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The molecule contains a tricyclic core with two carbonyl groups and a chlorine substituent. A nitrobenzene group is attached via a methylene linker. The nitro group (-NO\u2082) is a strong electron-withdrawing substituent on the aromatic ring.\",\n    \"Property Analysis\": \"GSK3-beta inhibitors often require balanced hydrophobicity and hydrogen bonding capacity. Nitro groups may reduce metabolic stability and introduce toxicity risks, while bulky substituents can hinder target binding.\",\n    \"Limitation in Source Molecule for Property\": \"The nitro group (-NO\u2082) may cause metabolic instability and off-target toxicity. The electron-deficient aromatic ring from the nitro group could reduce optimal \u03c0-\u03c0 stacking interactions with the kinase's hydrophobic pocket.\",\n    \"Optimization for Source Molecule\": \"Replace the nitrobenzene group with a pyridine ring to maintain aromaticity while introducing a hydrogen bond acceptor. This improves metabolic stability, reduces electron-withdrawing effects, and enhances target binding via nitrogen lone-pair interactions.\",\n    \"Final Target Molecule\": \"CN1C(=O)C(Cc2ccc(-c3ccncc3)cc2)NC(=O)c2cc(Cl)ccc21\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "CC(NC(=O)Nc1cc2[nH]nc(C(=O)NCC(O)C(F)F)c2cn1)c1ccccc1",
        "tgt": "CCNC(=O)Nc1n[nH]c2cc(NC(=O)NC(C)c3ccccc3)ncc12",
        "src_logd": 3.0480045016161963,
        "tgt_logd": 3.1648517753575938,
        "src_solubility": 1.2374637828938284,
        "tgt_solubility": 0.7185693581895091,
        "src_clint": 0.9796109183539856,
        "tgt_clint": 0.7233311003742355,
        "src_qed": 0.40133187250114755,
        "tgt_qed": 0.4753851027049683,
        "src_drd2": 0.0019777965004172957,
        "tgt_drd2": 0.004281842785184458,
        "src_jnk3": 0.08,
        "tgt_jnk3": 0.08,
        "src_gsk": 0.16,
        "tgt_gsk": 0.46,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The source molecule contains a central benzene ring substituted with an ethylamine group linked to a urea moiety (NC(=O)N). This urea connects to a bicyclic aromatic system (naphthyridine-like core) with a fluorinated ethanol substituent (C(O)C(F)F) and a secondary amide group (C(=O)NCC...). The structure includes hydrogen bond donors/acceptors (urea, amide, NH in the bicyclic ring) and hydrophobic regions (benzene, fluorinated group).\",\n    \"Property Analysis\": \"GSK3-beta inhibitors typically require (1) hydrogen bonding motifs to interact with the ATP-binding pocket (e.g., urea/amide for hinge-region interactions), (2) hydrophobic substituents for affinity, and (3) balanced lipophilicity for cell permeability. The fluorinated ethanol may enhance binding but could introduce metabolic instability.\",\n    \"Limitation in Source Molecule for Property\": \"1) The fluorinated ethanol (C(O)C(F)F) may cause metabolic instability due to oxidative susceptibility. 2) The ethyl group (CC) on the central benzene is suboptimal for hydrophobic pocket engagement. 3) The bicyclic core\u2019s substitution pattern may limit hinge-region hydrogen bonding efficiency.\",\n    \"Optimization for Source Molecule\": \"1) Replace fluorinated ethanol with a metabolically stable hydrophobic group (e.g., cyclopropyl). 2) Substitute the ethyl group with a bulkier hydrophobic substituent (e.g., isopropyl) to enhance van der Waals interactions. 3) Reposition the urea moiety on the bicyclic core to optimize hydrogen bonding with the kinase hinge region. 4) Introduce a methyl group to improve lipophilicity and reduce rotational freedom.\",\n    \"Final Target Molecule\": \"CCNC(=O)Nc1n[nH]c2cc(NC(=O)NC(C)c3ccccc3)ncc12\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "CCCCCCNc1ncc2cc(-c3c(Cl)cccc3Cl)c(=O)n(C)c2n1",
        "tgt": "Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(F)cc3)nc21",
        "src_logd": 4.602686997434328,
        "tgt_logd": 4.161576950062332,
        "src_solubility": -0.2416368304367759,
        "tgt_solubility": -0.2030186490850588,
        "src_clint": 1.96810030017846,
        "tgt_clint": 1.850757843172192,
        "src_qed": 0.5425819671378154,
        "tgt_qed": 0.5007846843579575,
        "src_drd2": 0.007539507288525973,
        "tgt_drd2": 0.007630203750125282,
        "src_jnk3": 0.21,
        "tgt_jnk3": 0.44,
        "src_gsk": 0.23,
        "tgt_gsk": 0.73,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The molecule contains a bicyclic purine-like core with a dichlorophenyl group, a hexylamine chain, and a methyl-substituted nitrogen. The carbonyl group and aromatic systems suggest potential kinase-binding interactions.\",\n    \"Property Analysis\": \"GSK3-beta inhibitors often require hydrogen-bond donors/acceptors (e.g., carbonyl groups), hydrophobic interactions (e.g., aryl halides), and balanced lipophilicity. The hexyl chain may reduce solubility, while the methyl group limits hydrogen-bonding potential.\",\n    \"Limitation in Source Molecule for Property\": \"1) Long hexyl chain increases lipophilicity, impairing solubility/bioavailability. 2) Methyl group on N prevents hydrogen-bond donation. 3) Limited electronic modulation in the amine substituent.\",\n    \"Optimization for Source Molecule\": \"1) Replace hexylamine with para-fluorophenyl-aniline to enhance solubility and introduce halogen bonding. 2) Remove methyl group to enable hydrogen-bond donation from the ring nitrogen. 3) Retain dichlorophenyl for hydrophobic interactions while optimizing substitution patterns.\",\n    \"Final Target Molecule\": \"Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(Nc3ccc(F)cc3)nc21\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "CCOCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccnc(Oc2ccccc2O)n1",
        "tgt": "CCOCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccnc(NC(C)COC)n1",
        "src_logd": 2.6191073931426336,
        "tgt_logd": 2.840945783810952,
        "src_solubility": 1.565085661514777,
        "tgt_solubility": 1.7997074559112882,
        "src_clint": 1.7606640047094084,
        "tgt_clint": 2.268933146389996,
        "src_qed": 0.47558058110397533,
        "tgt_qed": 0.5878163849085585,
        "src_drd2": 0.003407010740726863,
        "tgt_drd2": 0.002759385593348446,
        "src_jnk3": 0.08,
        "tgt_jnk3": 0.28,
        "src_gsk": 0.26,
        "tgt_gsk": 0.57,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The source molecule contains a central oxazole ring with a fluorine-substituted phenyl group attached via a carbonyl group and a pyrimidine ring linked to a di-substituted phenol. Key features include a fluorine atom (electron-withdrawing group) and polar oxygen atoms in the phenol and ether groups.\",\n    \"Property Analysis\": \"GSK3-beta inhibition typically benefits from hydrogen bond donors/acceptors, hydrophobic interactions, and aromatic stacking. The fluorine enhances binding via hydrophobic/electrostatic interactions, but the phenol group may limit metabolic stability and cell permeability due to high polarity and susceptibility to phase II metabolism.\",\n    \"Limitation in Source Molecule for Property\": \"The phenol group (Oc2ccccc2O) introduces high polarity, reducing membrane permeability. The ether linkage (Oc2ccccc2O) lacks a hydrogen bond donor, limiting interactions with the kinase's active site. Metabolic instability of the phenol may shorten half-life.\",\n    \"Optimization for Source Molecule\": \"Replace the phenol group with a substituted amine to introduce a hydrogen bond donor while maintaining moderate lipophilicity. Substitute the ether oxygen with a secondary amine (NH) linked to a methoxyethyl group to enhance binding affinity and metabolic stability.\",\n    \"Final Target Molecule\": \"CCOCn1oc(=O)c(-c2ccc(F)cc2)c1-c1ccnc(NC(C)COC)n1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "COc1cc(Cc2cnc(N)nc2N)ccc1OCc1ccc(-c2csnn2)cc1",
        "tgt": "COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1",
        "src_logd": 2.8359362124190266,
        "tgt_logd": 2.3016011490209807,
        "src_solubility": 0.6736106701405413,
        "tgt_solubility": 1.3523920493571038,
        "src_clint": 1.6707167972622998,
        "tgt_clint": 1.7216869176486909,
        "src_qed": 0.46671610350834175,
        "tgt_qed": 0.6621176234986874,
        "src_drd2": 0.002479905763938141,
        "tgt_drd2": 0.0014556349067854646,
        "src_jnk3": 0.03,
        "tgt_jnk3": 0.0,
        "src_gsk": 0.31,
        "tgt_gsk": 0.65,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The source molecule contains two methoxy-substituted benzene rings connected via a flexible ethyl linker. One benzene ring is attached to a pyrimidine group with dual amine substituents, while the other has a thiadiazole (-CSNN-) moiety. The pyrimidine and thiadiazole groups may contribute to hydrogen bonding and aromatic interactions, but the ethyl linker introduces conformational flexibility.\",\n    \"Property Analysis\": \"The methoxy groups enhance hydrophobicity, potentially aiding membrane permeability. The pyrimidine amines improve solubility and hydrogen-bonding capacity. However, the thiadiazole may reduce metabolic stability due to sulfur susceptibility to oxidation. The flexible linker could hinder optimal binding to the rigid ATP-binding pocket of GSK3-beta.\",\n    \"Limitation in Source Molecule for Property\": \"1) Thiadiazole (-CSNN-) introduces metabolic instability. 2) Flexible ethyl linker reduces conformational rigidity, weakening target binding. 3) Limited \u03c0-\u03c0 stacking optimization due to substituent positioning on the benzene rings.\",\n    \"Optimization for Source Molecule\": \"1) Replace thiadiazole with a stable oxadiazole (-CONN-) to improve metabolic stability. 2) Replace the flexible ethyl linker with a rigid ether bridge (C-O-C) to enforce binding conformation. 3) Introduce additional methoxy groups on the benzene rings to enhance hydrophobic interactions and \u03c0-\u03c0 stacking in the kinase pocket.\",\n    \"Final Target Molecule\": \"COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "COCCn1c(=O)c(-c2ccc(OC)cc2)nc2cnc(OCc3ccccc3)nc21",
        "tgt": "COCCn1c(=O)c(-c2ccc(OC)cc2)nc2cnc(Nc3cccc(OC)c3)nc21",
        "src_logd": 3.5316015033629067,
        "tgt_logd": 3.726260581529064,
        "src_solubility": 0.9651062287066776,
        "tgt_solubility": 0.7262109094386929,
        "src_clint": 1.9757224712765773,
        "tgt_clint": 1.914101341228185,
        "src_qed": 0.4344143101108159,
        "tgt_qed": 0.4519600512888049,
        "src_drd2": 0.0002888685651374253,
        "tgt_drd2": 0.0011215217148278485,
        "src_jnk3": 0.07,
        "tgt_jnk3": 0.39,
        "src_gsk": 0.11,
        "tgt_gsk": 0.54,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The source molecule contains a bicyclic core with a carbonyl group, methoxy substituents, and an ethoxy-linked benzyl group. The ethoxy group (OCc3ccccc3) is attached to the pyrimidine ring via an oxygen atom.\",\n    \"Property Analysis\": \"GSK3-beta inhibitors often require hydrogen bond donors/acceptors for ATP-binding site interactions. The carbonyl group acts as an acceptor, but the ethoxy group lacks direct hydrogen-bonding capability and introduces steric bulk, potentially hindering optimal binding.\",\n    \"Limitation in Source Molecule for Property\": \"The ethoxy-linked benzyl group (OCc3ccccc3) lacks hydrogen bond donation, reduces polarity, and may cause steric clashes in the binding pocket, limiting inhibitory activity.\",\n    \"Optimization for Source Molecule\": \"Replace the ethoxy group (OCc3ccccc3) with an aniline-derived substituent (Nc3cccc(OC)c3). This introduces a secondary amine as a hydrogen bond donor, retains a methoxy group for lipophilic balance, and reduces steric bulk while maintaining aromatic interactions.\",\n    \"Final Target Molecule\": \"COCCn1c(=O)c(-c2ccc(OC)cc2)nc2cnc(Nc3cccc(OC)c3)nc21\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "CC(NC(=O)Nc1cc2[nH]nc(OCCOC(F)(F)F)c2cn1)c1ccc(F)cc1",
        "tgt": "CC(NC(=O)Nc1cc2[nH]nc(NC(=O)N3CC(F)(F)C3)c2cn1)c1ccc(F)cc1",
        "src_logd": 4.660211082675319,
        "tgt_logd": 3.059269528578461,
        "src_solubility": -0.0899719830412189,
        "tgt_solubility": 0.7435656121828202,
        "src_clint": 1.0881511115581863,
        "tgt_clint": 0.6156076694452269,
        "src_qed": 0.39231728182937986,
        "tgt_qed": 0.5043938348165536,
        "src_drd2": 0.002239264722445145,
        "tgt_drd2": 0.0022872218177184917,
        "src_jnk3": 0.1,
        "tgt_jnk3": 0.12,
        "src_gsk": 0.18,
        "tgt_gsk": 0.52,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The molecule contains a pyrimidine ring core with substituents: (1) a urea-linked cyclopropyl group, (2) a para-fluorophenyl group, and (3) a flexible O-linked trifluoroethoxyethyl chain. The pyrimidine nitrogen participates in hydrogen bonding, while fluorine atoms enhance lipophilicity.\",\n    \"Property Analysis\": \"GSK3-beta inhibition requires strong hydrogen bonding with the kinase hinge region (e.g., via pyrimidine N and urea groups) and optimal hydrophobic interactions. The trifluoroethoxyethyl chain may lack rigidity and precise interactions with the hydrophobic pocket.\",\n    \"Limitation in Source Molecule for Property\": \"The flexible ethylene glycol linker (OCCOC) reduces binding affinity due to entropy penalties. The trifluoroethoxy group lacks hydrogen-bonding capacity, limiting interactions with the hydrophobic pocket's polar residues.\",\n    \"Optimization for Source Molecule\": \"Replace the O-linked trifluoroethoxyethyl chain with a rigid urea-linked cyclopropane bearing CF2 groups. This enhances (1) hydrogen bonding via the added urea NH, (2) rigidity via the cyclopropane ring, and (3) hydrophobic/electrostatic interactions via CF2 groups.\",\n    \"Final Target Molecule\": \"CC(NC(=O)Nc1cc2[nH]nc(NC(=O)N3CC(F)(F)C3)c2cn1)c1ccc(F)cc1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    },
    {
        "src": "Cn1c(=O)c(-c2c(Cl)cccc2Cl)cc2cnc(NCCCN3CCOCC3)nc21",
        "tgt": "COc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1",
        "src_logd": 2.954245279848664,
        "tgt_logd": 4.14711893029954,
        "src_solubility": 1.9126198768475369,
        "tgt_solubility": -0.1358903317440678,
        "src_clint": 1.949086793965369,
        "tgt_clint": 1.8819898249492104,
        "src_qed": 0.5830057360670298,
        "tgt_qed": 0.4935322643431872,
        "src_drd2": 0.10334333193736699,
        "tgt_drd2": 0.003049181732089922,
        "src_jnk3": 0.28,
        "tgt_jnk3": 0.34,
        "src_gsk": 0.24,
        "tgt_gsk": 0.61,
        "type": "large",
        "raw_cot": "",
        "cot_result": "{\n    \"Structural Analysis of Source Molecule\": \"The molecule contains a quinazolinone core substituted with a dichlorophenyl group at position 4 and a flexible morpholine-containing side chain at position 2. The structure includes a planar heteroaromatic system, a carbonyl group, and halogenated hydrophobic regions.\",\n    \"Property Analysis\": \"The dichlorophenyl group enhances hydrophobic interactions with the ATP-binding pocket of GSK3-beta. The morpholine side chain may improve solubility but introduces excessive flexibility, reducing binding entropy. The N-methyl group on the quinazolinone limits hydrogen-bonding opportunities.\",\n    \"Limitation in Source Molecule for Property\": \"1) High flexibility of the morpholine-containing side chain reduces binding affinity. 2) Lack of hydrogen-bond donors for kinase hinge-region interactions. 3) Suboptimal spatial placement of hydrophobic groups for pocket complementarity.\",\n    \"Optimization for Source Molecule\": \"1) Replace morpholine with a rigid methoxyphenyl group to reduce entropy loss. 2) Introduce a phenolic -OH as a hydrogen-bond donor. 3) Reposition substituents to align with key hydrophobic subpockets. 4) Maintain quinazolinone core for ATP-binding affinity.\",\n    \"Final Target Molecule\": \"COc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1\"\n}",
        "total_entity": 0,
        "error_entity": 0
    }
]